MLICM
NUTX

Metropolitan Life Insurance Company (MetLife)’s Nutex Health NUTX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-108
Closed -$16.4K – 2497
2023
Q1 		$16.4K Hold
108
– – ﹤0.01% 1983
2022
Q4 		$30.8K Buy
+108
New +$20.7K ﹤0.01% 1776

Other funds holding NUTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BHWM
Beaird Harris Wealth Management Dallas, Texas $1.6B AUM 16.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NUTX Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nutex Health (NUTX) in Q2 2023, closing a stake of 108 shares — an estimated $16.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NUTX in Q4 2022 and held it in 2 quarters. The position peaked at $30.8K in Q4 2022. 74 funds tracked by Wall St. Rank hold NUTX as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nutex Health position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 108 Nutex Health shares in Q2 2023, an estimated $16.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nutex Health in Q4 2022 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nutex Health position peaked at $30.8K in Q4 2022.
  • 74 funds tracked by Wall St. Rank held Nutex Health as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.